Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, announced a new contract for the installation of a Proteus ONE[1] proton therapy solution with Proton International Arkansas LLC – a joint venture formed by Proton International, the University of Arkansas for Medical Sciences (UAMS), Baptist Health, and Arkansas Children’s.
News | Proton Therapy
IBA and Proton International Sign Contract for Proteus ONE Proton Therapy Solution in Arkansas

January 3, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and ...

Time January 03, 2022
arrow
IBA (Ion Beam Applications S.A), a world leader in particle accelerator technology, announced the opening of its INDux training center to maximize talent, share experiences and optimize knowledge of both customers and employees at its headquarters in Louvain-La-Neuve, Belgium.
News | Radiation Oncology
IBA Launches INDux Training Center to Optimize Customer Performance

December 30, 2021 — IBA (Ion Beam Applications S.A), a world leader in particle accelerator technology, announced the ...

Time December 30, 2021
arrow
Role of P3HT MW and polyimide substrate thickness on the functionality of curved X-ray detectors. Loading and unloading P–h curves for the a) NP-BHJ films containing different P3HT MW and b) polyimide substrates of different thicknesses. Misfit strain as a function of both radius of curvature and substrate thickness for NP-BHJ film based on c) P3HT A and d) P3HT D. Misfit strain between the film and substrate increases when thinner substrates and lower P3HT MW are used. Photograph indicating the tendency of
News | Radiation Therapy
Safer X-rays and Radiation Therapy a Step Closer Thanks to Surrey Research

December 29, 2021 — Researchers at the University of Surrey have identified key design rules for making curved X-ray ...

Time December 29, 2021
arrow
Here is a list of the Top 10 most read pieces of content on ITNonline.com from the month of December 2021.
Feature | Radiology Business | By Melinda Taschetta-Millane
Top 10: Most Read Radiology Technology Content in December 2021

Here is a list of the Top 10 most read pieces of content on ITNonline.com from the month of December 2021. This is based ...

Time December 23, 2021
arrow
Neurosurgeon Adam Robin, M.D., surgically implants a GammaTile device for the first time in Michigan. Image courtesy of Henry Ford Health System
News | Radiation Therapy
Henry Ford Health System First in Michigan to Implant Novel Therapy for Recurrent Brain Tumors

December 22, 2021 — Surgeons at Henry Ford Health System have treated a patient with a recurrent brain tumor by ...

Time December 22, 2021
arrow
RayCare 5B features full user configurability of all workflow configuration settings, including the possibility to create advanced workflow automation, from the administrator’s workspace.
News | Radiation Oncology
RayCare 5B Provides Cancer Clinics with User Configurable Workflows for Radiation Therapy

December 22, 2021 — RayCare 5B features full user configurability of all workflow configuration settings, including the ...

Time December 22, 2021
arrow
 IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the installation of a Proteus ONE proton therapy solution with the New Mexico Cancer Center in Albuquerque, NM, USA.
News | Proton Therapy
IBA and New Mexico Cancer Center Sign Contract to Install a Proteus ONE

December 22, 2021 — IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology and the world’s ...

Time December 22, 2021
arrow
Immunolight LLC, a clinical stage biopharmaceutical firm leading the way in advancing technologies to transform cancer treatment, announced today it is now recruiting patients for a phase 1 study of its X-PACT Cancer Treatment system in Breast, Melanoma, Sarcoma and Head and Neck Cancers, to be conducted at Duke University Medical Center.
News | Radiation Oncology
Immunolight, LLC Now Recruiting Patients for Phase 1 Trial of the X-PACT System in Solid Tumors

December 20, 2021 — Immunolight LLC, a clinical stage biopharmaceutical firm leading the way in advancing technologies ...

Time December 20, 2021
arrow
A versatile light-sheet microscope developed at the University of Washington can provide surgeons with real-time pathology data to guide cancer-removal surgeries and can also non-destructively examine tumor biopsies in 3-D. Image courtesy of Mark Stone/University of Washington
News | Prostate Cancer
3-D Imaging Method May Help Doctors Better Determine Prostate Cancer Aggressiveness

December 10, 2021 — Prostate cancer is the most common cancer for men and, for men in the United States, it's the second ...

Time December 10, 2021
arrow
Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the signing of a definitive agreement to acquire Computerized Imaging Reference Systems, Inc. (“CIRS”), a leading provider of medical imaging and radiation therapy phantoms serving the medical industry.
News | Radiation Therapy
Mirion Technologies to Acquire Computerized Imaging Reference Systems

December 10, 2021 — Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring ...

Time December 10, 2021
arrow
The American Society for Radiation Oncology (ASTRO) issued the following statement from ASTRO Board of Directors Chair Laura A. Dawson, M.D., FASTRO, in response to today's introduction of the Supporting Health Care Providers During the COVID-19 Pandemic Act in the U.S. House of Representatives.
News | Radiation Oncology
ASTRO Urges Congress to Pass Legislation Delaying RO Model and Protecting Medicare Beneficiaries' Access to Care

December 9, 2021 — The American Society for Radiation Oncology (ASTRO) issued the following statement from ASTRO Board ...

Time December 09, 2021
arrow
Figure 1. Left image shows breast MRI in 41-year-old patient without IUD. Right image shows increased parenchymal enhancement in the same patient 27 months after IUD placement.
Feature | Radiology Imaging | By Melinda Taschetta-Millane
Top 10: Most Read Radiology Technology Content in November 2021

December 8, 2021 — Here is a list of the Top 10 most read pieces of content on ITNonline.com from the month of November ...

Time December 08, 2021
arrow
After the absorption of an X-ray photon, the water molecule can bend up so far that after only about ten femtoseconds (quadrillionths of a second) both hydrogen atoms (grey) are facing each other, with the oxygen atom (red) in the middle. This motion can be studied by absorbing a second X-ray photon. Credit: DESY, Ludger Inhester
News | Molecular Imaging
X-ray Laser Reveals How Radiation Damage Arises

December 7, 2021 — An international research team has used the X-ray laser European XFEL to gain new insights into how ...

Time December 07, 2021
arrow
RefleXion Medical Inc., a therapeutic oncology company, announced that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device Designation for its biology-guided radiotherapy (BgRT) for use in treating lung tumors.
News | Radiation Therapy
RefleXion Receives Breakthrough Device Designation for Lung Cancer Treatment

December 6, 2021 — RefleXion Medical Inc., a therapeutic oncology company, announced that the U.S. Food and Drug ...

Time December 06, 2021
arrow
CIRS specializes in the design, development and commercialization of tissue equivalent medical imaging and radiation therapy phantoms for the radiotherapy and radio-diagnostic markets.
News | Nuclear Imaging
Mirion Technologies Completes Acquisition of Computerized Imaging Reference Systems, Inc.

December 3, 2021 — Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring ...

Time December 03, 2021
arrow
Figure 1. Proportion of U.S. states offering equivalent early prioritization for COVID vaccination for patients with cancer and patients over the age of 65 as recommended by the Centers for Disease Control and Prevention.
News | Coronavirus (COVID-19)
Cancer Patients Overlooked in COVID-19 Vaccine Rollout

December 2, 2021 — Almost two-thirds of U.S. states failed to prioritize cancer patients for COVID-19 vaccinations ...

Time December 02, 2021
arrow
Videos | Radiation Therapy
VIDEO: Sedating Children With Movies Rather Than Drugs for Radiation Therapy

Jeffrey T. Chapman, a medical student at the University of Texas Southwestern Medical Center, Explains how watching ...

Time November 24, 2021
arrow
IBA, a leader in particle accelerator technology, and NorthStar Medical Radioisotopes LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced a new contract in which NorthStar will purchase a third Rhodotron TT300 HE electron beam accelerator from IBA.
News | Nuclear Imaging
IBA and NorthStar Medical Radioisotopes Sign Contract for Rhodotron Electron Beam Accelerator for Commercial Production of Therapeutic Radioisotope Actinium-225 (Ac-225)

November 22, 2021 — IBA, a leader in particle accelerator technology, and NorthStar Medical Radioisotopes LLC, a global ...

Time November 22, 2021
arrow
Lung cancer screening is recommended only for those who are at high risk for the disease — adults ages 50–80 who smoke at least 20 packs a year—but even among members of that high-risk group, screening rates remain low, ranging from 5% to 20% of those eligible for the screening CT scan.
News | Lung Imaging
Lung Cancer Screening Rates Increase With Access to Medicare

November 19, 2021 — Lung cancer screening is recommended only for those who are at high risk for the disease — adults ...

Time November 19, 2021
arrow
The CE-IVD marked Aiforia Clinical AI Model for Lung Cancer; PD-L1 is intended for use by pathologists in supporting them to detect and calculate the levels of the biomarker in non-small cell lung cancer cases.
News | Artificial Intelligence
Aiforia Achieves CE-IVD Mark for Clinical PD-L1 AI Model in Lung Cancer Diagnostics

November 18, 2021 — Worldwide the most common cause of cancer mortality in 2020 was lung cancer, with an estimated 1.80 ...

Time November 18, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now